Log in to save to my catalogue

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2491619090

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease

About this item

Full title

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease

Publisher

Cham: Springer International Publishing

Journal title

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2020-12, Vol.34 (6), p.713-721

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

The inflammatory bowel diseases (IBDs) are chronic immune-mediated inflammatory disorders, including ulcerative colitis (UC) and Crohn’s disease (CD). IBD results from a complex interplay between environmental, microbial, and genetic factors to create an abnormal immunological response leading to intestinal inflammation. Many pathways driving infla...

Alternative Titles

Full title

Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2491619090

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2491619090

Other Identifiers

ISSN

1173-8804

E-ISSN

1179-190X

DOI

10.1007/s40259-020-00451-w

How to access this item